NOVNQ — NVN Liquidation Share News
0.000.00%
Last trade - 00:00- $0.02m
- -$4.60m
- $23.68m
Novan Inc expected to post a loss of 60 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Discovery, Illumina, Comtech Telecommunications
U.S. STOCKS ON THE MOVE-WeWork, Oracle Corp, Boeing Co
Novan surges on buying dermatology drug maker EPI Health
Brief: Novan Acquires EPI Health
Brief: Novan May Offer And Sell Shares Of Up To $50 Mln Of Its Common Stock
Novan Inc reports results for the quarter ended in December - Earnings Summary
Brief: Novan Reports Full Year 2021 Financial Results And Provides Corporate Update
Brief: Novan Inc Files For Mixed Shelf Of Up To $150 Million - SEC Filing
Novan Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Novan Inc Reported Qtrly Loss Per Share $0.34
Novan Inc reports results for the quarter ended in September - Earnings Summary
Brief: Novan Announces Preclinical Data And Intent To Advance SB019 For Treatment Of COVID-19
Novan Inc expected to post a loss of 42 cents a share - Earnings Preview
Novan Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Novan Appoints Brian M. Johnson As Chief Commercial Officer And Receives Conditional FDA Acceptance Of Proposed Brand Name KINSOLUS For SB206 In Molluscum Contagiosum
Novan Inc expected to post a loss of 42 cents a share - Earnings Preview
Novan Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Novan Reports Safety Data From B-SIMPLE4 Pivotal Phase 3 Study Of SB206